125 related articles for article (PubMed ID: 33929788)
1. Incorporating cytologic adequacy assessment into precision oncology workflow using telepathology: An institutional experience.
Al Zoughbi W; Kim D; Alperstein SA; Ohara K; Manohar J; Greco N; Khani F; Robinson BD; Rao RA; Elemento O; Mosquera JM; Siddiqui MT
Cancer Cytopathol; 2021 Nov; 129(11):874-883. PubMed ID: 33929788
[TBL] [Abstract][Full Text] [Related]
2. Utilization of cytology smears improves success rates of RNA-based next-generation sequencing gene fusion assays for clinically relevant predictive biomarkers.
Ramani NS; Chen H; Broaddus RR; Lazar AJ; Luthra R; Medeiros LJ; Patel KP; Rashid A; Routbort MJ; Stewart J; Tang Z; Bassett R; Manekia J; Barkoh BA; Dang H; Roy-Chowdhuri S
Cancer Cytopathol; 2021 May; 129(5):374-382. PubMed ID: 33119213
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic utility of next-generation sequencing on FNA biopsies of melanocytic uveal lesions.
Han LM; Khanafshar E; Afshar AR; Calkins SM
Cancer Cytopathol; 2020 Jul; 128(7):499-505. PubMed ID: 32196967
[TBL] [Abstract][Full Text] [Related]
4. Improving Adequacy of Small Biopsy and Fine-Needle Aspiration Specimens for Molecular Testing by Next-Generation Sequencing in Patients With Lung Cancer: A Quality Improvement Study at Dartmouth-Hitchcock Medical Center.
Padmanabhan V; Steinmetz HB; Rizzo EJ; Erskine AJ; Fairbank TL; de Abreu FB; Tsongalis GJ; Tafe LJ
Arch Pathol Lab Med; 2017 Mar; 141(3):402-409. PubMed ID: 27763790
[TBL] [Abstract][Full Text] [Related]
5. Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies.
Roy-Chowdhuri S; Chen H; Singh RR; Krishnamurthy S; Patel KP; Routbort MJ; Manekia J; Barkoh BA; Yao H; Sabir S; Broaddus RR; Medeiros LJ; Staerkel G; Stewart J; Luthra R
Mod Pathol; 2017 Apr; 30(4):499-508. PubMed ID: 28084342
[TBL] [Abstract][Full Text] [Related]
6. Performance of next-generation sequencing on small tumor specimens and/or low tumor content samples using a commercially available platform.
Morris SM; Subramanian J; Gel ES; Runger GC; Thompson EJ; Mallery DW; Weiss GJ
PLoS One; 2018; 13(4):e0196556. PubMed ID: 29702695
[TBL] [Abstract][Full Text] [Related]
7. Preanalytic Variables in Cytology: Lessons Learned From Next-Generation Sequencing-The MD Anderson Experience.
Roy-Chowdhuri S; Stewart J
Arch Pathol Lab Med; 2016 Nov; 140(11):1191-1199. PubMed ID: 27333361
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of next-generation sequencing for the identification of clinically relevant variants in cytology smears in lung adenocarcinoma.
Baum JE; Zhang P; Hoda RS; Geraghty B; Rennert H; Narula N; Fernandes HD
Cancer Cytopathol; 2017 Jun; 125(6):398-406. PubMed ID: 28272845
[TBL] [Abstract][Full Text] [Related]
9. Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid Tumors.
Goswami RS; Luthra R; Singh RR; Patel KP; Routbort MJ; Aldape KD; Yao H; Dang HD; Barkoh BA; Manekia J; Medeiros LJ; Roy-Chowdhuri S; Stewart J; Broaddus RR; Chen H
Am J Clin Pathol; 2016 Feb; 145(2):222-37. PubMed ID: 27124905
[TBL] [Abstract][Full Text] [Related]
10. Using "residual" FNA rinse and body fluid specimens for next-generation sequencing: An institutional experience.
Wei S; Lieberman D; Morrissette JJ; Baloch ZW; Roth DB; McGrath C
Cancer Cytopathol; 2016 May; 124(5):324-9. PubMed ID: 26682952
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Genomic Profiling of Malignant Effusions in Patients with Metastatic Lung Adenocarcinoma.
Yang SR; Lin CY; Stehr H; Long SR; Kong CS; Berry GJ; Zehnder JL; Kunder CA
J Mol Diagn; 2018 Mar; 20(2):184-194. PubMed ID: 29269277
[TBL] [Abstract][Full Text] [Related]
12. Utility of rapid on-site evaluation for needle core biopsies and fine-needle aspiration cytology done for diagnosis of mass lesions of the liver.
Walia S; Aron M; Hu E; Chopra S
J Am Soc Cytopathol; 2019; 8(2):69-77. PubMed ID: 31287422
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting the success of next-generation sequencing in cytology specimens.
Roy-Chowdhuri S; Goswami RS; Chen H; Patel KP; Routbort MJ; Singh RR; Broaddus RR; Barkoh BA; Manekia J; Yao H; Medeiros LJ; Staerkel G; Luthra R; Stewart J
Cancer Cytopathol; 2015 Nov; 123(11):659-68. PubMed ID: 26230354
[TBL] [Abstract][Full Text] [Related]
14. FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.
Treece AL; Montgomery ND; Patel NM; Civalier CJ; Dodd LG; Gulley ML; Booker JK; Weck KE
Cancer Cytopathol; 2016 Jun; 124(6):406-14. PubMed ID: 26882436
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of percutaneous core biopsies adequate for next generation genomic sequencing.
Sabir SH; Krishnamurthy S; Gupta S; Mills GB; Wei W; Cortes AC; Mills Shaw KR; Luthra R; Wallace MJ
PLoS One; 2017; 12(12):e0189651. PubMed ID: 29281680
[TBL] [Abstract][Full Text] [Related]
16. Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling.
Roy-Chowdhuri S; Mehrotra M; Bolivar AM; Kanagal-Shamanna R; Barkoh BA; Hannigan B; Zalles S; Ye W; Duose D; Broaddus R; Staerkel G; Wistuba I; Medeiros LJ; Luthra R
Mod Pathol; 2018 Jul; 31(7):1036-1045. PubMed ID: 29463880
[TBL] [Abstract][Full Text] [Related]
17. Selective deployment of dynamic telecytology for rapid evaluation of cytology smears: assessment of workflow processes and role of cytopathology fellows as on-site operators.
Sarode VR; Pena V; Yan S; Kirkpatrick J; Wanzer D
J Am Soc Cytopathol; 2021; 10(6):577-584. PubMed ID: 34238730
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non-small-cell Lung Cancer.
Stoy SP; Segal JP; Mueller J; Furtado LV; Vokes EE; Patel JD; Murgu S
Clin Lung Cancer; 2018 May; 19(3):230-238.e2. PubMed ID: 29277564
[TBL] [Abstract][Full Text] [Related]
19. Tissue recommendations for precision cancer therapy using next generation sequencing: a comprehensive single cancer center's experiences.
Cho M; Ahn S; Hong M; Bang H; Van Vrancken M; Kim S; Lee J; Park SH; Park JO; Park YS; Lim HY; Kang WK; Sun JM; Lee SH; Ahn MJ; Park K; Kim DH; Lee S; Park W; Kim KM
Oncotarget; 2017 Jun; 8(26):42478-42486. PubMed ID: 28477007
[TBL] [Abstract][Full Text] [Related]
20. Rapid on-site evaluation using telecytology: A major cancer center experience.
Lin O; Rudomina D; Feratovic R; Sirintrapun SJ
Diagn Cytopathol; 2019 Jan; 47(1):15-19. PubMed ID: 29575752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
